Ataxin 7-like 3B (ATXN7L3B) is a protein that, while sharing similarity with ataxin-7, a protein known for its involvement in spinocerebellar ataxia type 7 (SCA7), has its own distinct roles and functions within the cellular milieu. The "like" in its name refers to the homology it shares with ataxin-7, particularly in certain domains that suggest a potential for overlap in function or interaction with similar biological molecules.ATXN7L3B is a lesser-studied member of the ataxin family of proteins, which are characterized by their roles in neurodegenerative diseases and their involvement in various cellular processes, including gene regulation, RNA metabolism, and protein homeostasis. While the specific functions of ATXN7L3B are not as well-defined as those of ataxin-7, it is believed that ATXN7L3B may be implicated in similar pathways, potentially influencing gene expression regulation and chromatin remodeling due to the presence of domains typically associated with these functions.
The protein's structure suggests that it may interact with components of the transcription machinery or chromatin-modifying complexes, implicating it in the control of transcriptional activity. Given its homology with ataxin-7, ATXN7L3B may also be a part of protein complexes that are involved in the regulation of gene expression, possibly through modifying chromatin structure or influencing the transcriptional machinery directly.Though not directly associated with any known neurodegenerative diseases, the study of ATXN7L3B could provide insights into the broader family of ataxin proteins and their roles in cellular homeostasis and disease. As research progresses, determining the specific interactions and pathways that ATXN7L3B is involved in will be crucial for understanding its biological significance and the potential impact of its dysregulation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, potentially reducing transcription of certain genes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, could decrease methylation and affect gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Non-nucleoside DNA methyltransferase inhibitor, might lead to demethylation and altered gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Another DNA methyltransferase inhibitor, could similarly affect gene expression patterns. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that can change chromatin structure and gene expression. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
PARP inhibitor, while primarily used for DNA repair, may have off-target effects on gene regulation. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Antitumor antibiotic that can bind to DNA and potentially affect transcription factor binding. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and can inhibit RNA polymerase action, thereby reducing gene transcription. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Known to inhibit transcriptional activity in various cell types, might affect a range of genes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, could indirectly affect protein synthesis and gene expression. | ||||||